249 related articles for article (PubMed ID: 23470080)
1. Copeptin as a biomarker in cardiac disease.
Giannopoulos G; Deftereos S; Panagopoulou V; Kossyvakis C; Kaoukis A; Bouras G; Pyrgakis V; Cleman MW
Curr Top Med Chem; 2013; 13(2):231-40. PubMed ID: 23470080
[TBL] [Abstract][Full Text] [Related]
2. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
[TBL] [Abstract][Full Text] [Related]
3. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
JAMA; 2011 May; 305(20):2088-95. PubMed ID: 21610241
[TBL] [Abstract][Full Text] [Related]
4. Use of copeptin in emergency patients with cardiac chief complaints.
Searle J; Slagman A; Stockburger M; Vollert JO; Müller C; Muller R; Möckel M
Eur Heart J Acute Cardiovasc Care; 2015 Oct; 4(5):393-402. PubMed ID: 25318480
[TBL] [Abstract][Full Text] [Related]
5. Copeptin testing in acute myocardial infarction: ready for routine use?
Reinstadler SJ; Klug G; Feistritzer HJ; Metzler B; Mair J
Dis Markers; 2015; 2015():614145. PubMed ID: 25960596
[TBL] [Abstract][Full Text] [Related]
6. Copeptin as a biomarker in heart failure.
Balling L; Gustafsson F
Biomark Med; 2014; 8(6):841-54. PubMed ID: 25224940
[TBL] [Abstract][Full Text] [Related]
7. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
[TBL] [Abstract][Full Text] [Related]
8. Copeptin does not add diagnostic information to high-sensitivity troponin T in low- to intermediate-risk patients with acute chest pain: results from the rule out myocardial infarction by computed tomography (ROMICAT) study.
Karakas M; Januzzi JL; Meyer J; Lee H; Schlett CL; Truong QA; Rottbauer W; Bamberg F; Dasdemir S; Hoffmann U; Koenig W
Clin Chem; 2011 Aug; 57(8):1137-45. PubMed ID: 21673277
[TBL] [Abstract][Full Text] [Related]
9. Rapidly rule out acute myocardial infarction by combining copeptin and heart-type fatty acid-binding protein with cardiac troponin.
Jacobs LH; van Borren M; Gemen E; van Eck M; van Son B; Glatz JF; Daniels M; Kusters R
Ann Clin Biochem; 2015 Sep; 52(Pt 5):550-61. PubMed ID: 25732130
[TBL] [Abstract][Full Text] [Related]
10. The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department.
Nickel CH; Bingisser R; Morgenthaler NG
BMC Med; 2012 Jan; 10():7. PubMed ID: 22264220
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
[TBL] [Abstract][Full Text] [Related]
12. Copeptin - a new diagnostic and prognostic biomarker in neurological and cardiovascular diseases.
Baranowska B; Kochanowski J
Neuro Endocrinol Lett; 2019 Dec; 40(5):207-214. PubMed ID: 32112544
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic value of copeptin and cancer antigen 125 in acute heart failure patients with atrial fibrillation and their correlations with short-term cardiovascular events].
Ding Y; Wang Q; Yang Y; Wang L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Nov; 30(11):1024-1028. PubMed ID: 30541639
[TBL] [Abstract][Full Text] [Related]
14. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.
Khan SQ; Dhillon OS; O'Brien RJ; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
Circulation; 2007 Apr; 115(16):2103-10. PubMed ID: 17420344
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic and prognostic value of copeptin in cardiovascular disease, current status, and prospective.
Parizadeh SM; Ghandehari M; Parizadeh MR; Ferns GA; Ghayour-Mobarhan M; Avan A; Hassanian SM
J Cell Biochem; 2018 Nov; 119(10):7913-7923. PubMed ID: 30011137
[TBL] [Abstract][Full Text] [Related]
16. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department.
Bahrmann P; Bahrmann A; Hofner B; Christ M; Achenbach S; Sieber CC; Bertsch T
Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):137-47. PubMed ID: 25002708
[TBL] [Abstract][Full Text] [Related]
17. C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study.
Narayan H; Dhillon OS; Quinn PA; Struck J; Squire IB; Davies JE; Ng LL
Clin Sci (Lond); 2011 Jul; 121(2):79-89. PubMed ID: 21309746
[TBL] [Abstract][Full Text] [Related]
18. The stress hormone copeptin: a new prognostic biomarker in acute illness.
Katan M; Christ-Crain M
Swiss Med Wkly; 2010; 140():w13101. PubMed ID: 20872295
[TBL] [Abstract][Full Text] [Related]
19. Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort.
Smaradottir MI; Ritsinger V; Gyberg V; Norhammar A; Näsman P; Mellbin LG
Diab Vasc Dis Res; 2017 Mar; 14(2):69-76. PubMed ID: 28118730
[TBL] [Abstract][Full Text] [Related]
20. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
